Health 

Intensive Lipitor Therapy Was Associated With Reduced Risk Of Cardiovascular Events In Two High-Risk Patient Groups - Lipitor® (atorvastatin calcium) 80 mg was associated with a significantly reduced risk of major cardiovascular events compared with Lipitor 10 mg among patients with both coronary heart disease (CHD) and chronic kidney disease (CKD) who were obese or had metabolic syndrome. These data, from two sub-analyses of the Treating to New Targets (TNT) trial that were designed and completed following the completion of TNT, were presented today at the 59th Annual Scientific Session of the American College of Cardiology (ACC) in Atlanta, Ga...

Tue, 16 Mar 2010 19:00:00 PDT

Statement From HHS Secretary Kathleen Sebelius On House Budget Committee Mark Up Action On Health Reform Legislation - The progress made in the House Budget Committee is good news for health reform and the millions of Americans who are victims of the worst abuses of the insurance companies. Across the country, Americans have seen their health insurance premiums skyrocket or been denied coverage due to pre-existing conditions. Health care costs are crushing business, family, and government budgets. And without action, we know these problems will only get worse. Today, the Budget Committee took an important step forward toward reform...

Tue, 16 Mar 2010 18:00:00 PDT

Irvine Scientific(R) Receives 510(k) Clearance For The Use Of Vit Kit(R)-Freeze And Vit Kit(R)-Thaw With Embryos Of All Stages - Irvine Scientific, a pioneer in developing products specifically for the Assisted Reproductive Technology (ART) community, announced that the U.S. Food and Drug Administration (FDA) has approved their products intended for vitrification of pronuclear (PN) zygotes through day 3 cleavage and blastocyst stage embryos within the fertility area. The approval for both Vit Kit®-Freeze and Vit Kit®-Thaw, joins a long list of industry firsts from Irvine Scientific...

Tue, 16 Mar 2010 17:00:00 PDT

Sernova Announces Interim Results From Key Preclincal Study With Its Proprietary Cell Pouch SystemTM - Sernova Corp. (TSX VENTURE:SVA) today reported interim results from a key porcine diabetes study evaluating the safety and efficacy of the Cell Pouch System™. Interim results, to be presented at the American Society of Artificial Internal Organs 56th Annual Conference, Baltimore, MD, May 27th-29th in a podium presentation, confirm that the Cell Pouch System™ establishes a biological environment capable of preserving the functionality of therapeutic cells...

Tue, 16 Mar 2010 16:00:00 PDT

BIOLASE Announces FDA 510(K) Clearance Of ILase TM Personal Laser For Dental Market - BIOLASE Technology, Inc. (NASDAQ: BLTI), the world's leading dental laser company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its iLase™ diode laser, the world's first personal laser for dentists and hygienists for performing a full-range of minimally invasive soft-tissue and hygiene procedures. The iLase is the first completely self-contained, hand-held dental laser that includes the laser, user interface, battery power, and controls in a single, integrated handpiece with no foot pedals or cords attached...

Tue, 16 Mar 2010 15:00:00 PDT

St. Jude Medical Announces Multiple Enhancements To Industry-Leading PressureWire FFR Measurement System - St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, announced several updates to its PressureWire(TM) platform, including a new marketing agreement with Siemens Medical Solutions USA, for the wireless PressureWire(TM) Aeris and the availability of the next-generation of PressureWire(TM) Certus technology, at the American College of Cardiology (ACC) and the Society of Interventional Radiology (SIR) annual meetings...

Tue, 16 Mar 2010 14:00:00 PDT